Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Prices of 851 essential drug formulations cut in past 2 year: Government

      Prices of 851 essential drug formulations cut in past 2 year: Government

      Ruby Khatun Khatun15 March 2018 10:00 AM IST
      New Delhi: Prices of 851 essential drug formulations were cut, mostly in the 5-40 percent range, in the past 2 years, the government said.In a written...
      Roche CEO says new drugs will offset biosimilar incursions

      Roche CEO says new drugs will offset biosimilar incursions

      Ruby Khatun Khatun15 March 2018 9:45 AM IST
      ZURICH: Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from...
      Teva rebuffs EU pay-for-delay charge at hearing

      Teva rebuffs EU pay-for-delay charge at hearing

      Ruby Khatun Khatun15 March 2018 9:30 AM IST
      BRUSSELS: Israeli drugmaker Teva rebuffed EU antitrust charges of making an illegal deal with rival Cephalon to delay selling a cheaper generic...
      New Proposal: Separate Shelf for Generics In Pharmacies, Pharmacists can Prescribe Alternatives

      New Proposal: Separate Shelf for Generics In Pharmacies, Pharmacists can Prescribe Alternatives

      Ruby Khatun Khatun14 March 2018 5:32 PM IST
      The government is also considering a proposal to allow pharmacists to sell a generic version of a drug if the doctor prescribes the branded...
      Lupin launches generic oral contraceptive tablets in US

      Lupin launches generic oral contraceptive tablets in US

      Ruby Khatun Khatun14 March 2018 3:16 PM IST
      New Delhi: Pharma major Lupin said it has launched its Tydemy tablets, indicated for use by women to prevent pregnancy, in the US.The launch follows...
      Zydus Cadila gets USFDA nod for Tizanidine tablets

      Zydus Cadila gets USFDA nod for Tizanidine tablets

      Ruby Khatun Khatun14 March 2018 10:30 AM IST
      New Delhi: Cadila Healthcare said its group firm Zydus Cadila has received final approval from the US health regulator for its generic version of...
      Cognizant to acquire bolder healthcare solutions

      Cognizant to acquire bolder healthcare solutions

      Ruby Khatun Khatun14 March 2018 10:00 AM IST
      Cognizant announced it has agreed to acquire Bolder Healthcare Solutions, a privately-held provider of revenue cycle management (RCM) solutions to...
      GSK wins new reprieve as Hikmas generic Advair delayed again

      GSK wins new reprieve as Hikma's generic Advair delayed again

      Ruby Khatun Khatun14 March 2018 9:45 AM IST
      GlaxoSmithKline (GSK) has won a further reprieve for its blockbuster Advair lung drug after U.S. regulators insisted Hikma Pharmaceuticals conduct a...
      Impax broke US antitrust law by delaying generic drug, jury told

      Impax broke US antitrust law by delaying generic drug, jury told

      Ruby Khatun Khatun14 March 2018 9:30 AM IST
      BOSTON: Impax Laboratories Inc went to trial on Monday over allegations by major retailers and consumers that the company agreed to delay launching a...
      New TB drugs in India: Government negotiation begin for Bedaquiline, Delamanid

      New TB drugs in India: Government negotiation begin for Bedaquiline, Delamanid

      Ruby Khatun Khatun13 March 2018 5:33 PM IST
      New Delhi: To provide an improved and better access to the TB patients with new antibiotic drugs, the government has begun its negotiation with...
      Health bodies push for compulsory licence for two drugs on MDR-TB

      Health bodies push for compulsory licence for two drugs on MDR-TB

      Ruby Khatun Khatun13 March 2018 10:30 AM IST
      New Delhi: Survivors of drug-resistant tuberculosis, health organizations and the TB community have appealed to Prime Minister Narendra Modi to allow...
      HealthAssure raises Rs 6.5 crore from The HR Fund

      HealthAssure raises Rs 6.5 crore from The HR Fund

      Ruby Khatun Khatun13 March 2018 10:00 AM IST
      New Delhi: HealthAssure, a health-tech platform, on Monday said it has received $1 million (Rs 6.5 crore) in funding led by The HR Fund and is looking...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok